Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
Eligibility Criteria
Inclusion Criteria: * Individuals of both genders. * Must be in good physical health. * Age between 20 and 65 years. * Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region. * Must possess the willingness and ability to understand and provide informed consent, as well as effectively communicate with study personnel. Exclusion Criteria: * Pregnant or breastfeeding female. * Age below 20 or above 65 years. * History of neuromuscular disorders, such as myasthenia gravis. * History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study. * Recent treatment history within the past 6 months in the forehead or glabellar region, including: * Ablative laser procedures. * Radiofrequency device treatments. * Ultrasound device treatments. * Medium to deep chemical peels. * Temporary soft tissue augmentation. * Semi-permanent soft tissue augmentation wi